Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERIVEDGE for Basal cell carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 49 adverse event reports in the FDA FAERS database where ERIVEDGE was used for Basal cell carcinoma.

Most Reported Side Effects for ERIVEDGE

Side Effect Reports % Deaths Hosp.
Muscle spasms 16 21.6% 0 1
Ageusia 12 16.2% 0 1
Alopecia 11 14.9% 0 1
Squamous cell carcinoma 11 14.9% 0 2
Weight decreased 11 14.9% 1 4
Dysgeusia 10 13.5% 0 2
Nausea 10 13.5% 1 3
Death 9 12.2% 9 0
Fatigue 9 12.2% 0 1
Decreased appetite 6 8.1% 0 3
Diarrhoea 5 6.8% 1 2

Other Indications for ERIVEDGE

Product used for unknown indication (15)

Other Drugs Used for Basal cell carcinoma

VISMODEGIB (5,329) SONIDEGIB (900) IMIQUIMOD (276) FLUOROURACIL (141) CEMIPLIMAB-RWLC (42) CEMIPLIMAB (38) PEMBROLIZUMAB (35) NIVOLUMAB (29) INGENOL MEBUTATE (18) LENALIDOMIDE (16)

Related Pages

ERIVEDGE Full Profile All Basal cell carcinoma Drugs ERIVEDGE Demographics ERIVEDGE Timeline